Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in Phase 3 clinical trials, with the potential to be the first approved ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Be it from tap water on a vacation, some dodgy chicken, or something the kids have brought home from school, we've almost all ...

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

leading to severe symptoms and, in some cases, hospitalization,” said Stéphane Bancel, CEO of Moderna, in a statement last fall. “By advancing our investigational norovirus vaccine into a ...

Massachusetts-based Moderna will likely be the first to manufacture a bird flu vaccine, backed by hundreds of millions in government funding. The biopharmaceutical giant is developing the vaccine ...

Moderna's goal isn't to prevent people from getting norovirus entirely. That's a high bar for any vaccine, and one that's especially difficult to achieve with norovirus because the symptoms start ...